J.J. Picazo

460 total citations
27 papers, 325 citations indexed

About

J.J. Picazo is a scholar working on Epidemiology, Infectious Diseases and Otorhinolaryngology. According to data from OpenAlex, J.J. Picazo has authored 27 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 9 papers in Infectious Diseases and 4 papers in Otorhinolaryngology. Recurrent topics in J.J. Picazo's work include Pneumonia and Respiratory Infections (13 papers), Respiratory viral infections research (8 papers) and Viral gastroenteritis research and epidemiology (5 papers). J.J. Picazo is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Respiratory viral infections research (8 papers) and Viral gastroenteritis research and epidemiology (5 papers). J.J. Picazo collaborates with scholars based in Spain. J.J. Picazo's co-authors include Fabiola Martin, María Garcés‐Sánchez, Iciar Rodríguez-Avial, Federico Martinón‐Torres, F. Giménez Sánchez, Esther Culebras, Carmen Betriú, Octavio Corral, Margarita Rubio Alonso and Carlos Rodrigo and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and Postgraduate Medical Journal.

In The Last Decade

J.J. Picazo

25 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.J. Picazo Spain 11 178 144 60 41 37 27 325
Andrew A. Mahony Australia 10 148 0.8× 151 1.0× 41 0.7× 73 1.8× 24 0.6× 20 339
K. Green Canada 6 265 1.5× 80 0.6× 78 1.3× 14 0.3× 49 1.3× 8 381
Arufumi Shiota Japan 14 175 1.0× 179 1.2× 34 0.6× 47 1.1× 17 0.5× 38 472
Nefise Öztoprak Türkiye 10 150 0.8× 141 1.0× 53 0.9× 68 1.7× 27 0.7× 37 392
LE Nicolle Canada 8 284 1.6× 67 0.5× 22 0.4× 36 0.9× 15 0.4× 28 402
Andrea Bedini Italy 14 221 1.2× 287 2.0× 25 0.4× 38 0.9× 24 0.6× 31 505
Mahshid Talebi‐Taher Iran 12 178 1.0× 113 0.8× 33 0.6× 39 1.0× 11 0.3× 63 459
Yoona Rhee United States 9 76 0.4× 159 1.1× 48 0.8× 72 1.8× 18 0.5× 25 332
Tewodros Tesfa Ethiopia 12 121 0.7× 73 0.5× 47 0.8× 24 0.6× 9 0.2× 32 329
Jacqueline Nguyen France 9 122 0.7× 67 0.5× 17 0.3× 17 0.4× 29 0.8× 22 255

Countries citing papers authored by J.J. Picazo

Since Specialization
Citations

This map shows the geographic impact of J.J. Picazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Picazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Picazo more than expected).

Fields of papers citing papers by J.J. Picazo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Picazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Picazo. The network helps show where J.J. Picazo may publish in the future.

Co-authorship network of co-authors of J.J. Picazo

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Picazo. A scholar is included among the top collaborators of J.J. Picazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Picazo. J.J. Picazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González‐Romo, Fernando, J.J. Picazo, A Rojas, et al.. (2017). [Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update].. PubMed. 30(2). 142–168. 22 indexed citations
2.
Rodríguez-Avial, Iciar, et al.. (2011). In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. Journal of Antimicrobial Chemotherapy. 67(1). 167–169. 59 indexed citations
3.
Sánchez, F. Giménez, et al.. (2009). Calendario vacunal de la Asociación Española de Pediatría: Recomendaciones 2009. Anales de Pediatría. 70(1). 72–82. 48 indexed citations
4.
Martinón‐Torres, Federico, et al.. (2008). ¿Por qué hay más empiemas pediátricos en España?. Anales de Pediatría. 68(2). 158–164. 13 indexed citations
5.
Sánchez, F. Giménez, et al.. (2008). Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2008. Anales de Pediatría. 68(1). 63–69. 15 indexed citations
6.
Sánchez, F. Giménez, et al.. (2008). Criterios de inclusión de vacunas en el calendario de la Asociación Española de Pediatría. Anales de Pediatría. 68(1). 58–62. 4 indexed citations
7.
Mensa, José, José Barberán, Pedro Llinares, et al.. (2008). [Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus].. PubMed. 21(4). 234–58. 19 indexed citations
8.
Castillo, Fernando del, et al.. (2007). Consenso Nacional sobre otitis media aguda. Anales de Pediatría. 66(6). 603–610. 13 indexed citations
9.
Castillo, Fernando del, et al.. (2007). National Consensus on Acute Otitis Media. Acta Otorrinolaringologica (English Edition). 58(6). 225–231. 4 indexed citations
10.
Sánchez, F. Giménez, et al.. (2007). Calendario de vacunación de la Asociación Española de Pediatría: recomendaciones 2007. Anales de Pediatría. 66(1). 62–69. 16 indexed citations
11.
Castillo, Fernando del, et al.. (2007). Consenso Nacional sobre otitis media aguda. Acta Otorrinolaringológica Española. 58(6). 225–231. 10 indexed citations
12.
Sánchez, F. Giménez, et al.. (2006). El papel de la vacuna frente a rotavirus en los calendarios de vacunación infantil. Anales de Pediatría. 64(6). 573–577. 11 indexed citations
13.
Rodríguez-Avial, Iciar, et al.. (2006). In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates. International Journal of Antimicrobial Agents. 27(4). 303–306. 10 indexed citations
14.
Martinón‐Torres, Federico, et al.. (2006). Vacuna frente al virus del papiloma humano: un nuevo reto para el pediatra. Anales de Pediatría. 65(5). 461–469. 7 indexed citations
15.
Martinón‐Torres, Federico, et al.. (2006). Recomendaciones del Comité Asesor de Vacunas de la Asociación Española de Pediatría: vacunación antigripal campaña 2006-2007. Anales de Pediatría. 65(3). 252–255. 7 indexed citations
16.
Picazo, J.J., et al.. (2003). Microbiología de las infecciones neumocócicas. Resistencia a los antibióticos. Anales de Pediatría. 1. 3–13. 1 indexed citations
17.
Alonso, Margarita Rubio, et al.. (2003). Community-Acquired Respiratory Infections. PubMed. 15(6). 289–98. 30 indexed citations
18.
Quirós, Alfredo Blanco, et al.. (2002). Incidencia de la infección neumocócica invasora en niños menores de dos años. Vacuna neumocócica conjugada heptavalente. Situación en España. Anales de Pediatría. 57(4). 287–289. 6 indexed citations
19.
Rodríguez-García, J L, et al.. (2001). Systemic sarcoidosis with spleen involvement. Postgraduate Medical Journal. 77(906). 265–265. 1 indexed citations
20.
Cisterna, R, et al.. (1998). [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].. PubMed. 11(3). 245–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026